Dibutyl [2,2'-bipyridine]-4,4'-dicarboxylate, 98.0%, 250mg

METHYL 4-BROMO-2-CHLORO-6-FLUOROBENZOATE, 95.0%, 10g

2-(3-(FLUOROMETHYL)AZETIDIN-1-YL)ETHAN-1-OL, 95%, 1g

2-(morpholin-4-ylmethyl)aniline sulfate hydrate, 95.0%, 1g

3-Amino-4-cyclobutyl-2-oxobutanamide hydrochloride, 95.0%, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxaldehyde>98.0%(GC)(T)5g

1-(4-Fluorobenzyl)-5-oxopyrrolidine-3-carboxylic acid, 97.0%, 10g

5-(tert-Butyloxycarbonyamino)methyl-3-(4-(trifluoromethyl)phenyl)-[1,2,4]oxadiazole, 95.0%, 1g

tert-butyl 9-benzyl-3,9-diazaspiro[5.5]undecane-3-carboxylate, 98%, 500mg

5-Chloro-2-(trifluoromethyl)benzyl alcohol, 95.0%, 250mg

2-Methyl-3-trifluoromethylbenzenesulfonylchloride, 5g

bScope BS.1153-EPLPH para contraste de fases. Triocular con oculares HWF 10x/20 mm y revólver cuádruple E-plan Phase 10/20/S40 S100x

2-Chloro-4-(trifluoromethyl)pyrimidine-5-carbonyl chloride, 95.0%, 2.5g